473 related articles for article (PubMed ID: 17280921)
1. Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer.
Hutton JL; Baracos VE; Wismer WV
J Pain Symptom Manage; 2007 Feb; 33(2):156-65. PubMed ID: 17280921
[TBL] [Abstract][Full Text] [Related]
2. Combination of flavor enhancement and chemosensory education improves nutritional status in older cancer patients.
Schiffman SS; Sattely-Miller EA; Taylor EL; Graham BG; Landerman LR; Zervakis J; Campagna LK; Cohen HJ; Blackwell S; Garst JL
J Nutr Health Aging; 2007; 11(5):439-54. PubMed ID: 17657366
[TBL] [Abstract][Full Text] [Related]
3. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation.
Epstein JB; Phillips N; Parry J; Epstein MS; Nevill T; Stevenson-Moore P
Bone Marrow Transplant; 2002 Dec; 30(11):785-92. PubMed ID: 12439702
[TBL] [Abstract][Full Text] [Related]
4. Taste and odor abnormalities in cancer patients.
Hong JH; Omur-Ozbek P; Stanek BT; Dietrich AM; Duncan SE; Lee YW; Lesser G
J Support Oncol; 2009; 7(2):58-65. PubMed ID: 19408458
[TBL] [Abstract][Full Text] [Related]
5. Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study.
Bernhardson BM; Tishelman C; Rutqvist LE
J Pain Symptom Manage; 2007 Oct; 34(4):403-12. PubMed ID: 17616338
[TBL] [Abstract][Full Text] [Related]
6. Assessing alterations in taste and their impact on cancer care.
Wismer WV
Curr Opin Support Palliat Care; 2008 Dec; 2(4):282-7. PubMed ID: 19060564
[TBL] [Abstract][Full Text] [Related]
7. Characterization of chemosensory alterations in advanced cancer reveals specific chemosensory phenotypes impacting dietary intake and quality of life.
Brisbois TD; de Kock IH; Watanabe SM; Baracos VE; Wismer WV
J Pain Symptom Manage; 2011 Apr; 41(4):673-83. PubMed ID: 21276701
[TBL] [Abstract][Full Text] [Related]
8. Associations between physical activity and quality of life in cancer patients receiving palliative care: a pilot survey.
Lowe SS; Watanabe SM; Baracos VE; Courneya KS
J Pain Symptom Manage; 2009 Nov; 38(5):785-96. PubMed ID: 19775864
[TBL] [Abstract][Full Text] [Related]
9. Taste changes experienced by patients receiving chemotherapy.
Wickham RS; Rehwaldt M; Kefer C; Shott S; Abbas K; Glynn-Tucker E; Potter C; Blendowski C
Oncol Nurs Forum; 1999 May; 26(4):697-706. PubMed ID: 10337648
[TBL] [Abstract][Full Text] [Related]
10. Olfactory changes among patients receiving chemotherapy.
Bernhardson BM; Tishelman C; Rutqvist LE
Eur J Oncol Nurs; 2009 Feb; 13(1):9-15. PubMed ID: 19028142
[TBL] [Abstract][Full Text] [Related]
11. An epidemiological evaluation of the prevalence of malnutrition in Spanish patients with locally advanced or metastatic cancer.
Segura A; Pardo J; Jara C; Zugazabeitia L; Carulla J; de Las Peñas R; García-Cabrera E; Luz Azuara M; Casadó J; Gómez-Candela C
Clin Nutr; 2005 Oct; 24(5):801-14. PubMed ID: 15993517
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced taste and smell changes influence food perception in cancer patients.
Drareni K; Bensafi M; Giboreau A; Dougkas A
Support Care Cancer; 2021 Apr; 29(4):2125-2132. PubMed ID: 32870414
[TBL] [Abstract][Full Text] [Related]
13. The relationship between taste, olfaction, and nutrition in the cancer population.
Farmer MN; Raddin RS; Roberts JD
J Support Oncol; 2009; 7(2):70-2. PubMed ID: 19408461
[No Abstract] [Full Text] [Related]
14. Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapy.
Dahele M; Skipworth RJ; Wall L; Voss A; Preston T; Fearon KC
J Pain Symptom Manage; 2007 Jun; 33(6):676-85. PubMed ID: 17360150
[TBL] [Abstract][Full Text] [Related]
15. [Food intake, depressed appetite and chemosensory threshold in patients with cancer during chemotherapy].
Ovesen LF; Hannibal JG; Sørensen M; Allingstrup L
Ugeskr Laeger; 1993 Mar; 155(11):793-6. PubMed ID: 8460430
[TBL] [Abstract][Full Text] [Related]
16. A ChemoSensory questionnaire for patients treated for cancer of the head and neck.
Goldberg AN; Shea JA; Deems DA; Doty RL
Laryngoscope; 2005 Dec; 115(12):2077-86. PubMed ID: 16369148
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy.
Gramignano G; Lusso MR; Madeddu C; Massa E; Serpe R; Deiana L; Lamonica G; Dessì M; Spiga C; Astara G; Macciò A; Mantovani G
Nutrition; 2006 Feb; 22(2):136-45. PubMed ID: 16459226
[TBL] [Abstract][Full Text] [Related]
18. [Development of taste disorders following FOLFOX-FOLFIRI therapy and its effects on the QOL of patients with colorectal cancer].
Takimoto N; Sugawara S; Iida A; Sakakibara T; Mori K; Sugiura M; Yamamura K; Adachi M
Gan To Kagaku Ryoho; 2009 Mar; 36(3):431-5. PubMed ID: 19295267
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of nutritional status and dietary intake in patients with advanced cancer on palliative care.
Bovio G; Bettaglio R; Bonetti G; Miotti D; Verni P
Minerva Gastroenterol Dietol; 2008 Sep; 54(3):243-50. PubMed ID: 18614973
[TBL] [Abstract][Full Text] [Related]
20. Aspects of taste and compliance in patients with cancer.
Ravasco P
Eur J Oncol Nurs; 2005; 9 Suppl 2():S84-91. PubMed ID: 16437761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
